UNC School of Medicine researcher David Margolis, MD, was one of the first researchers to resist the common view that HIV is an incurable infection
William A. Fischer II and David Wohl are taking part in a clinical trial at ELWA Hospital in Monrovia, Liberia, in which plasma from survivors of Ebola virus disease is given to patients who are battling the disease.
Graduate student Orrin Stone is creating molecular tools to pinpoint how and when cellular pathways trigger cell movement – or, in cancer, metastasis.
The common chemotherapy drug topotecan disrupts a gene integral for neuron communication, though the effects are reversible. The research also homes in on an underlying cause of autism.
To support the NIH BRAIN Initiative, Garret Stuber, PhD, will use a new kind of microscope to further his lab’s investigation of brain circuits related to obesity.
Garret Stuber, PhD, earns a UNC Hettleman prize for his research and promise as a young scientist uncovering the inner workings of the brain.
A study led by John R. Stephens, MD, finds that simple interventions, consisting of a change in computerized order set and presentation of evidence and data from group practice, led to significant improvement in the assessment and treatment of vitamin D deficiency in elderly patients with hip fracture.
Sickle cell trait in African-Americans associated with increased kidney disease risk, new research finds
Vimal Derebail, MD, MPH, is co-first author of the study and Abhijit Kshirsagar, MD, MPH, is co-senior author. Both are members of the UNC Kidney Center.
A novel siRNA-based molecule, developed by Chad Pecot, MD, successfully targets KRAS, a well-studied but hard to halt protein important for cancer development and metastasis.
A new study by UNC researchers confirms their surprising earlier finding: Patients who suffer a STEMI heart attack while while in the hospital for something else are more likely to die than patients who have the same type of heart attack outside the hospital.
UNC researchers and colleagues are the first to develop a mouse model that more accurately reflects human disease symptoms; they found a single gene crucial for disease severity.
UNC TV reporter Daniel Lane stopped by to interview Eric Ubil, PhD, who as a graduate student studied how fibroblasts that form scar tissue can be turned into endothelial cells to help repair the heart after a heart attack.
Hypertonic saline, developed into an effective treatment at UNC School of Medicine in collaboration with Australian researchers, has become a proven therapy for thousands of people with cystic fibrosis.
UNC Lineberger Comprehensive Cancer Center and the UNC Institute for Global Health & Infectious Diseases have received a $3.7 million grant from the National Cancer Institute (NCI) to study the growing worldwide cancer problem and expand the University’s efforts in Malawi to study and treat HIV-associated cancers.
The Society of Neuroscience recognizes the innovative research of Juan Song, PhD.
The research, led by Andrew C. Dudley, PhD, has implications for developing cancer drugs that target blood vessels that feed tumors.
Roth’s research to create innovative tools for neuroscientists and discover potential targets for therapeutics has earned him one of the highest honors in the field of medicine.
The partnership aims to create new drugs to help patients with lung diseases clear mucus, a major roadblock to normal respiratory health.
The collaboration of Mark Zylka, PhD, and Ben Philpot, PhD, led to a new discovery about potential underlying causes of autism
In cell lines, scientists at the joint UNC-NC State biomedical engineering program have shown that the new nano particles can stealthily enter cancer cells and release a known drug to attack tumors from the inside.